Available on demand. Live date. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion focusing on new technologies. The panelists discuss how the bioanalytical field could learn from other industries and why we should be introducing new technologies.
Available on demand. Register for our exclusive Coffee Chat focusing on developments in cell and gene therapies. This informal discussion centers around gene therapy medicinal products and their potential to change the way we fight disease.
Available on demand. LC–MS based large molecule bioanalysis platform was developed, validated and applied for drug screening and preclinical pharmacokinetics.
Available on demand. The demonstration of similar immunogenicity is a critical requirement for the demonstration of similarity between a biosimilar candidate and the respective reference product.
Webinar now available on demand. The aim of DMPK is to enable scientists to learn the safety and efficacy of new molecular entities. HRMS is an important analytical tool used to study DMPK that continues to gain traction when quantifying molecules.
Webinar now available on demand. Absolute quantitation of intact biotherapeutics is enabled through advances in immunocapture techniques coupled to LC–MS.
Webinar live date: Thursday 12 December 2019 07:00 [PST] 10:00 [EST] 15:00 [GMT]. On December 12, join us as we discuss, with supporting case studies, how hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue.
Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research using oligonucleotides, including the most common challenges encountered, key trends they have seen as the field develops and their opinions on the future outlook of the technology.
Webinar now available on demand. Learn about the sensitivity gains afforded by microflow chromatography vs high-flow and what potential this has for Met ID. See how this translates to stronger spectra in turn resulting in more metabolites being identified and characterized.
Thank you everyone who attended our live webinar ‘Exploratory biomarker testing: to qualify or validate the assay? The latest scientific and regulatory considerations for biomarker validation‘ in association with BioAgilytix.
The Pennsylvania-based CRO, Frontage Holdings Corporation (PA, USA), has completed the expansion of its bioanalytical laboratories in Exton (PA, USA). The expansion is designed to enhance the group’s bioanalytical capabilities.
Scientists at the Johns Hopkins Kimmel Cancer Center (MD, USA) have completed a proof-of-principle study with results indicating the potential for a urine test for prostate cancer. The study identified cancer-specific changes in urinary RNAs and metabolites.
A graphene-based wireless device developed by researchers at California Institute of Technology (CA, USA) could rapidly detect stress levels by quantitatively measuring cortisol concentrations in sweat.
To get a better understanding of the bioanalytical applications of chromatography we interviewed Makoto Tsunoda (University of Tokyo, Japan). Makoto described his research developing analytical methods to quantify endogenous compounds in a range of complex matrices.
As part of our feature examining lab-on-a-chip technology, we interviewed lab-on-a-chip expert, Aaron Wheeler from the University of Toronto (Canada). Aaron described his experience and research in the field and explained to us that the age of lab-on-a-chip is upon us.